According to the principles for the nomination committee in Xbrane Biopharma AB (”the Company” or ”Xbrane”) which were adopted at the annual general meeting on May 4, 2023, the nomination committee shall consist of three members, appointed by the Company’s three largest shareholders as of September 30, 2023. if a shareholder ceases to be one of the Company’s three largest shareholders before three months before the general meeting, the member must resign from the nomination committee and a new member appointed.

Based on the above, Oscar Bergman, appointed by Swedbank Robur Fonder, the company’s third largest shareholder as of September 30, 2023, resigned from the Nomination Committee.

The Chairman of the Board, Anders Tullgren is in contact with other larger shareholders, but as of today, the Nomination Committe consist of the following individuals:

Saeid Esmaeilzadeh, appointed by Systematic Group AB, the company’s largest shareholder

Bengt Göran Westman, the company’s second largest shareholder

Anders Tullgren, Xbrane’s Chairman of the Board, deputy member if necessary.

Saeid Esmaeilzadeh is appointed as the nomination committee’s Chairman.